Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
BIOR

BIOR - Biora Therapeutics, Inc. Stock Price, Fair Value and News

$0.220.00 (0.00%)
Market Closed

81/100

BIOR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

81/100

BIOR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.33

Target 3M

$0.28

Target 6M

$0.3

BIOR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BIOR Price Action

BIOR RSI Chart

BIOR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BIOR Valuation

Market Cap

995.0K

Price/Earnings (Trailing)

-0.03

Price/Free Cashflow

-0.02

MarketCap/EBT

-0.03

BIOR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.33

Target 3M

$0.28

Target 6M

$0.3

BIOR Fundamentals

BIOR Revenue

BIOR Earnings

BIOR Profitability

Free Cashflow Yield

-4.6K%

BIOR Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20240000
20230000
20221.2M828.0K726.0K305.0K
2021414.0K666.0K918.0K1.2M
2020113.3M73.3M36.8M162.0K
2019132.0M136.0M140.0M144.0M
2018000128.0M
Get all data in R, Python etc through our Historical Stock Data APIs

About Biora Therapeutics, Inc.

BIOR
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
 CEO
 WEBSITEbioratherapeutics.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES54

Biora Therapeutics, Inc. Frequently Asked Questions

BIOR is the stock ticker symbol of Biora Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jan 27 2026, market cap of Biora Therapeutics, Inc. is 994.99 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check BIOR's fair value in chart for subscribers.

The fair value guage provides a quick view whether BIOR is over valued or under valued. Whether Biora Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Biora Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BIOR.